Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | PLA2G4B | P0C869 | 5/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | PPARA | Q07869 | 1/20 | 0.54 |
| ▸ | RARB | P10826 | 3/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.51 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28446197 | 0.79 | CES2 (0.56) | L3MBTL1PARP10PKM | |
| SCHEMBL4119592 | 0.79 | GAA (0.67) | TP53TSHRPLA2G4BGAARARB | |
| SCHEMBL7114335 | 0.79 | PPARA (0.81) | TP53TSHRGAAPPARAL3MBTL1 | |
| SCHEMBL14689477 | 0.79 | PPARA (0.81) | TP53TSHRGAAPPARAL3MBTL1 | |
| SCHEMBL279013 | 0.79 | PPARA (0.81) | TP53TSHRGAAPPARAL3MBTL1 | |
| SCHEMBL6652325 | 0.79 | PPARA (0.81) | TP53TSHRGAAPPARAL3MBTL1 | |
| SCHEMBL2127003 | 0.79 | PPARA (0.81) | TP53TSHRGAAPPARAL3MBTL1 | |
| SCHEMBL2127341 | 0.79 | PPARA (0.81) | TP53TSHRGAAPPARAL3MBTL1 | |
| SCHEMBL20624042 | 0.79 | PPARA (0.81) | TP53TSHRGAAPPARAL3MBTL1 | |
| Bromomethane SCHEMBL30082988 | 0.78 | CES1 (0.45) | TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8829067-B2 | Polymerizable compositions with initiators containing several Ge atoms | IVOCLAR VIVADENT AG (LI) | 2014-09-09 | — | — | US | disclosed |
| US-20090239967-A1 | POLYMERIZABLE COMPOSITIONS WITH INITIATORS CONTAINING SEVERAL GE ATOMS | IVOCLAR VIVADENT AG (LI) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239967-A1 | POLYMERIZABLE COMPOSITIONS WITH INITIATORS CONTAINING SEVERAL GE ATOMS | GRIA1, COG1, GRIA4 | TP53 4349/4885TSHR 4751/4885PLA2G4B 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.